Celsense offers products that enable the real-time in vivo imaging of transplanted cells for therapeutic and diagnostic purposes. The mission of Celsense is to be the imaging standard for transplanted cells in human health.
Celsense has licensed two technologies from Carnegie Mellon University. Both “Cell Sense” and “Gene Sense” represent significant breakthroughs in the field of using Biologics to understand and treat disease.
Celsense has developed two additional technologies: “V-Sense,” an in situ cell labeling agent, and the “Celsense Workstation,” a software product to quantify the number of cells in a region of interest.
